Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: immediate results and six-month follow-up of the multicenter AngioJet registry. Possis Peripheral AngioJet Study AngioJet Investigators

Cathet Cardiovasc Diagn. 1998 Dec;45(4):386-93. doi: 10.1002/(sici)1097-0304(199812)45:4<386::aid-ccd7>3.0.co;2-q.

Abstract

We tested the efficacy of rheolytic thrombectomy in treating 21 patients (mean age 68+/-12 years; 66% male) and 22 vessels (limbs) who presented to the hospital within 2 weeks of the development of limb-threatening ischemia. Fifty-two percent had contraindications to use thrombolytics, and 57% had severe comorbidities. All of the vessels were occluded with thrombus on the initial angiogram. Procedural success was achieved in 20 limbs (91%). Three patients expired in the hospital, and one expired at follow-up due to nonvascular causes. Acute limb salvage was achieved in 18 of 19 limbs (95%) in the 18 survivors, and 6-month limb salvage was achieved in 16 of 18 limbs (89%) in the 17 survivors. Rheolytic thrombectomy is effective in restoring immediate blood flow in acute limb-threatening ischemia, especially in high-risk surgical patients or patients with contraindications to thrombolytic therapy.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Catheterization / instrumentation*
  • Comorbidity
  • Equipment Design
  • Extremities / blood supply*
  • Female
  • Follow-Up Studies
  • Graft Occlusion, Vascular / surgery
  • Humans
  • Ischemia / epidemiology
  • Ischemia / surgery*
  • Male
  • Middle Aged
  • Rheology
  • Thrombectomy / instrumentation*
  • Thrombectomy / methods
  • Thrombosis / surgery*
  • Treatment Outcome